Pharmafile Logo

Fresenius Kabi Ltd.

Fresenius Kabi is the leading European provider of clinical nutrition and infusion therapy offering a unique and comprehensive range of products and services for both hospital and home settings. From our expertise in nutrition and infusion therapies, and through dedication to people through innovation we are committed to becoming the preferred partner worldwide for saving, treatment and caring for chronically ill patients.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Cestrian Court, Eastgate Way, Runcorn, Cheshire, WA7 1NT
+44 (0) 1928-533 533

 Latest Content from PMHub 

Lucid Group Let Loose with the Launch of ‘Summer Fridays’

In-line with Lucid’s agile working policy, the company is introducing the concept of ‘Summer Fridays’ across all of its UK businesses in July and August.A ‘Summer Friday’ means that employees...

Webinar: Usability and UX: You’ve been asked to test…What next?

Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST

Event: EphMRA Annual Conference

We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland.

Research Partnership and Janssen awarded runner-up in MR Excellence Awards

We are delighted to announce that an entry by Janssen and Research Partnership for the 2019 EphMRA MR Excellence Awards has been awarded runner-up in the ‘Business Impact through Innovation’...

Lucid demonstrates continual investment in its central services with the appointment of its new Head of Talent, Resourcing and HR projects

Lucid group is excited to announce the appointment of its new head of Talent, Resourcing and HR projects, Olivia Emirali.Olivia joined Lucid in March this year to review recruitment and...

Fake News is Bad for your Health

Ill informed patients make poor health decisions

Secrets of Pharma Advertising

If the goal of branding is to be different, why do so many Pharma brand ads look the same?

Precision medicine with precision management and precision pricing; ensuring affordability in the cell and gene therapy era

The third plenary session at ISPOR in New Orleans focused on affordability in the face of new and expensive therapies and asked the question “is affordability driving a need to...

A variety of backgrounds, a unified purpose

How did Bedrock become Bedrock? We asked members of the Bedrock team how they found their way into the (somewhat hidden) world of medical communications, and what they love about...

The founders of Lucid Group reflect on their beginnings in MedComms and why it’s the place to be #Medcomms Day

In support of MedComms Day we caught up with the co-founders of Lucid Group, Jan Steele (COO) and Dennis O’Brien (CEO), to discuss the aspirations that drove them to start...